Protas partners with Duke Clinical Research Institute
The partnership aims to transform the quality, accessibility and affordability of randomised clinical trials for common health conditions.
As a not-for-profit, our mission is to enable whole-system change in clinical trials. This means sharing our approach and knowledge with our community. From news about Protas, our partnerships and trials, to advice and guidance, discover more about our world.
The partnership aims to transform the quality, accessibility and affordability of randomised clinical trials for common health conditions.
The UKAS accredited certification is the international standard for information security management systems.
Protas announces the appointment of Professor Richard Haynes MBE DM FRCP to its Executive Team.
Protas is delighted to welcome Esther Krofah MPP to its Board of Directors.
Together, the three organisations are calling for actions not words in The Lancet.
Protas will provide expertise to the portfolio biopharma on a range of drug development programmes.
The international accreditation acknowledges our approach to quality.
Protas will advise GSK on clinical trial protocols across a range of late-phase investigational products.
Principles from global community initiative, which includes Protas, forms basis of new WHO guidance.
Protas has played a significant role in shaping three major policy efforts.
Maggie Payne has joined the Executive Team responsible for the leadership of Protas.
Protas announces the launch of its new Cantata platform.